Article Versions Notes

Giorgio C, Allodi M, Palese S, Grandi A, Tognolini M, Castelli R, Lodola A, Flammini L, Cantoni AM, Barocelli E, et al. UniPR1331: Small Eph/Ephrin Antagonist Beneficial in Intestinal Inflammation by Interfering with Type-B Signaling. Pharmaceuticals. 2021; 14(6):502. https://doi.org/10.3390/ph14060502

Giorgio, Carmine, Marika Allodi, Simone Palese, Andrea Grandi, Massimiliano Tognolini, Riccardo Castelli, Alessio Lodola, Lisa Flammini, Anna Maria Cantoni, Elisabetta Barocelli, and et al. 2021. "UniPR1331: Small Eph/Ephrin Antagonist Beneficial in Intestinal Inflammation by Interfering with Type-B Signaling" Pharmaceuticals 14, no. 6: 502. https://doi.org/10.3390/ph14060502

Giorgio, C., Allodi, M., Palese, S., Grandi, A., Tognolini, M., Castelli, R., Lodola, A., Flammini, L., Cantoni, A. M., Barocelli, E., & Bertoni, S. (2021). UniPR1331: Small Eph/Ephrin Antagonist Beneficial in Intestinal Inflammation by Interfering with Type-B Signaling. Pharmaceuticals, 14(6), 502. https://doi.org/10.3390/ph14060502